BMP mutants with decreased susceptibility to Noggin

Details for Australian Patent Application No. 2008345689 (hide)

Owner Stryker Corporation

Inventors Song, Kening; Alaoui-Ismaili, Moulay Hicham

Agent Griffith Hack

Pub. Number AU-A-2008345689

PCT Pub. Number WO2009/086131

Priority 61/008,754 21.12.07 US

Filing date 19 December 2008

Wipo publication date 9 July 2009

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

C07K 14/51 (2006.01) Peptides having more than 20 amino acids

Event Publications

10 June 2010 PCT application entered the National Phase

  PCT publication WO2009/086131 Priority application(s): WO2009/086131

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008345696-Benzimidazole compounds

2008345688-Imidazo [1,2-b] pyridazine compounds as modulators of liver X receptors